Nigeria keeps sending its patients to India, and the numbers behind that habit are large and long-standing, BusinessDay reported. For decades India has been the destination of choice for Nigerians who can afford to seek care abroad, a pattern that reflects both India’s strengths and the gaps in Nigeria’s own hospitals. The flow of Nigerian patients to India is one of the clearest medical tourism corridors in Africa, and it has proved stubborn. BusinessDay framed it as a decades-long dependence rather than a passing trend.
India’s pull in numbers
The scale reads most plainly in the visa data. Figures from the Indian High Commission show that 47 per cent of Nigerians granted Indian visas in 2013 travelled for medical reasons, about 18,000 visas that year, at an estimated cost of 41.6 billion naira in scarce foreign exchange, BusinessDay reported. That outflow has not slowed since. BusinessDay put the current figure at more than 5,000 Nigerians leaving each month for treatment, most bound for India but also for Europe and the United States. It is a steady export of patients, and of the naira that travels with them.
Why India wins the patients
Price does much of the pulling. Sanjay Jain, an Indian businessman based in Lagos, told an audience at the Mike Adenuga Center on Victoria Island on 22 March 2026 that Indian medical care runs 60 to 70 per cent cheaper than the equivalent in Western countries, BusinessDay reported. “Medical procedures in India are significantly more affordable,” Jain said. Nigerian patients travel to India for cardiac surgery, oncology, kidney transplants, neurosurgery, orthopaedic work and specialist eye treatment, drawn by internationally accredited hospitals and consistently high success rates in those fields.
Price is not the whole of it. Jain pointed to speed and logistics as much as cost. The Indian hospitals he described offer short waiting times where many systems make patients queue, a flexible medical visa that eases planning for the patient and the relatives who travel alongside, and dedicated international patient departments staffed by English-speaking coordinators. For a Nigerian family managing a cardiac or oncology case from abroad, that streamlined patient experience matters almost as much as the price on the invoice. Convenience, in medical tourism, is its own currency.
The bill Nigeria pays
Outbound medical tourism is expensive for the country. By the reckoning of the News Agency of Nigeria, it costs about $1 billion a year, a steady drain on foreign-exchange reserves that could otherwise fund the hospitals at home, BusinessDay reported. Jain noted early signs of change, some fresh investment in Nigeria’s health sector and a reported dip in medical tourism spending in early 2025, though he framed the shift as slow and far from settled.
What the outflow really measures
There is a way to read a figure like $1 billion that goes past the accounting. Medical tourism at this scale is a symptom rather than a strategy. Nigerians travel to India for the reasons patients travel anywhere, because the treatment they need is better, cheaper, faster, or simply unavailable at home. Those are the standing drivers of medical travel, and Nigeria’s outflow to India runs on nearly all of them at once. The visa data is really a map of what Nigeria’s own system cannot yet do, from cardiac surgery and neurosurgery to oncology and orthopaedic care, and every naira spent in Delhi or Chennai is a naira not spent building that capacity in Lagos or Abuja. The medical tourism outflow measures the gap, and the gap is the point.
The risk sits in the same place. Jain himself flagged the part that rarely reaches the brochure, that complications can surface after the patient flies home, into a health system that never saw the operation and may struggle to manage the follow-up. Continuity of care is one of the standing risks of medical travel, and it falls hardest on the countries that export the most patients. A cardiac procedure in Chennai is only as good as the aftercare waiting in Lagos.
The test for Nigeria
One way out is dull and slow, and it is not a single hospital. Nigeria will reduce its medical tourism outflow when it can hold specialists at home, equip the theatres they work in, and give a returning patient somewhere credible in Abuja or Lagos to be seen. The measurable sign will show in the same visa and spending figures that chart the problem: if the early-2025 dip Jain describes hardens into a trend, the domestic investment is working; if it fades, the $1 billion will keep leaving each year, and India will keep drawing the cardiac and neurosurgery cases. The country that fixes the dull machinery of specialist retention and working equipment keeps its patients at home. The one that announces hospitals without staffing them keeps funding India’s.
